Allison A. Divanovic, MD, is an associate professor of Pediatrics with the University of Cincinnati College of Medicine and is currently the associate director of the Fetal Heart Program and co-director of Medical Student and Resident Education.
A native of Cincinnati, Dr. Divanovic has completed all of her medical training locally, starting with medical school at the University of Cincinnati. She completed both her pediatric residency and cardiology fellowship at Cincinnati Children’s Hospital Medical Center. In addition to her three-year cardiology fellowship, she completed a fourth year of training in order to gain further expertise in fetal echocardiography, transthoracic and transesophageal echocardiography and neonatal cardiology.
Dr. Divanovic has been an attending staff member in the Heart Institute at Cincinnati Children’s Hospital Medical Center since 2009. Dr. Divanovic has been active in the pediatric and cardiology communities as a member of the American Heart Association, American Society of Echocardiography and the American Academy of Pediatrics.
MD: Univeristy of Cincinnati, Cincinnati, OH.
Residency: Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Fellowship: Pediatric Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Pediatric cardiology; fetal and neonatal cardiology; echocardiography
Fetal Care, Cardiac MRI
Echocardiographic predictors of cardiac involvement in the fetus with twin-twin transfusion syndrome; risk factors for intrauterine fetal demise in the fetus with congenital heart disease; optimization of outcomes after prenatal diagnosis of CHD; improvement in the prenatal identification of atrial septal restriction in the fetus with HLHS; social determinants of health that impact cardiac surgical outcomes
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Pulmonary venous Doppler patterns and midterm outcomes in fetuses with left-sided obstructive lesions and restrictive atrial septum. Prenatal Diagnosis. 2020; 40:776-784.
Obstetric Outcomes Associated with Fetal Cyanotic Congenital Heart Disease. American Journal of Perinatology: neonatal and maternal-fetal medicine. 2019; 36:701-708.
Diagnosis and Management of Kawasaki Disease. JAMA Pediatrics. 2019; 173:278-279.
Prenatal heart block screening in mothers with SSA/SSB autoantibodies: Targeted screening protocol is a cost-effective strategy. Congenital Heart Disease. 2019; 14:221-229.
Effect of fetal hemodynamics on growth in fetuses with single ventricle or transposition of the great arteries. Ultrasound in Obstetrics and Gynecology. 2018; 52:479-487.
Hemodynamic adaptation to suboptimal fetal growth in patients with single ventricle physiology. Echocardiography: a journal of cardiovascular ultrasound and allied techniques. 2018; 35:1378-1384.
Fetal somatic growth trajectory differs by type of congenital heart disease. Pediatric Research. 2018; 83:669-676.
First-Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta-Analysis. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease. 2017; 6:e007164.
Intrauterine fetal demise after prenatal diagnosis of congenital heart disease: assessment of risk. Prenatal Diagnosis. 2016; 36:142-147.
Estimated cardiac output and cardiovascular profile score in fetuses with high cardiac output lesions. Ultrasound in Obstetrics and Gynecology. 2013; 41:54-58.